These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 7554289)

  • 1. Detection of autoantibodies against oxidized low-density lipoproteins and of IgG-bound low density lipoproteins in patients with coronary artery disease.
    Boullier A; Hamon M; Walters-Laporte E; Martin-Nizart F; Mackereel R; Fruchart JC; Bertrand M; Duriez P
    Clin Chim Acta; 1995 Jun; 238(1):1-10. PubMed ID: 7554289
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Autoantibodies against MDA-LDL in subjects with severe and minor atherosclerosis and healthy population controls.
    van de Vijver LP; Steyger R; van Poppel G; Boer JM; Kruijssen DA; Seidell JC; Princen HM
    Atherosclerosis; 1996 May; 122(2):245-53. PubMed ID: 8769687
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Autoantibodies to malondialdehyde-modified low-density lipoprotein in patients with angiographically confirmed coronary artery disease.
    McDowell A; Young IS; Wisdom GB
    J Pharm Pharmacol; 2002 Dec; 54(12):1651-7. PubMed ID: 12542895
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Presence of autoantibodies against oxidatively modified low-density lipoprotein in essential hypertension: a biochemical signature of an enhanced in vivo low-density lipoprotein oxidation.
    Maggi E; Marchesi E; Ravetta V; Martignoni A; Finardi G; Bellomo G
    J Hypertens; 1995 Jan; 13(1):129-38. PubMed ID: 7759843
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Autoantibodies against oxidized low density lipoprotein in patients with angiographically verified coronary artery disease.
    Lehtimäki T; Lehtinen S; Solakivi T; Nikkilä M; Jaakkola O; Jokela H; Ylä-Herttuala S; Luoma JS; Koivula T; Nikkari T
    Arterioscler Thromb Vasc Biol; 1999 Jan; 19(1):23-7. PubMed ID: 9888862
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Detection of IgG-bound lipoprotein(a) immune complexes in patients with coronary heart disease.
    Wang J; Qiang H; Zhang C; Liu X; Chen D; Wang S
    Clin Chim Acta; 2003 Jan; 327(1-2):115-22. PubMed ID: 12482626
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increased autoantibodies against oxidized low-density lipoprotein in coronary circulation in patients with coronary spastic angina.
    Ogawa H; Soejima H; Takazoe K; Miyamoto S; Kajiwara I; Shimomura H; Sakamoto T; Yoshimura M; Kugiyama K; Kimura M; Yasue H
    Angiology; 2001 Mar; 52(3):167-74. PubMed ID: 11269779
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anti-modified LDL antibodies, LDL-containing immune complexes, and susceptibility of LDL to in vitro oxidation in patients with type 2 diabetes.
    Mironova MA; Klein RL; Virella GT; Lopes-Virella MF
    Diabetes; 2000 Jun; 49(6):1033-41. PubMed ID: 10866057
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Autoantibodies against oxidised low density lipoproteins in patients with coronary disease].
    Maggi E; Perani G; Falaschi F; Frattoni A; Martignoni A; Finardi G; Stefano PL; Simeone F; Paolini G; DeVecchi E
    Presse Med; 1994 Jul 2-9; 23(25):1158-62. PubMed ID: 7971845
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increased levels of autoantibodies against copper-oxidized low density lipoprotein, malondialdehyde-modified low density lipoprotein and cardiolipin in patients with rheumatoid arthritis.
    Cvetkovic JT; Wållberg-Jonsson S; Ahmed E; Rantapää-Dahlqvist S; Lefvert AK
    Rheumatology (Oxford); 2002 Sep; 41(9):988-95. PubMed ID: 12209031
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Auto-antibodies against oxidized LDL as a marker of coronary artery disease in patients with familial hypercholesterolaemia.
    Paiker JE; Raal FJ; von Arb M
    Ann Clin Biochem; 2000 Mar; 37 ( Pt 2)():174-8. PubMed ID: 10735360
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Autoantibodies against modified low-density lipoproteins in coronary artery disease.
    Tornvall P; Waeg G; Nilsson J; Hamsten A; Regnström J
    Atherosclerosis; 2003 Apr; 167(2):347-53. PubMed ID: 12818418
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Autoantibody against, malondialdehyde-modified low density lipoprotein in patients with non-diabetic unstable angina: a potential role in immunologic reaction of plaque instability.
    Kwon KH; Kwon HM; Hong BK; Kim DS; Lee JY; Ryu SK; Park BE; Park HY; Kim JH; Yoon YW; Cho SY; Kim HS
    Yonsei Med J; 2002 Apr; 43(2):203-10. PubMed ID: 11971214
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Autoantibody against oxidized low-density lipoproteins may be enhanced by cigarette smoking.
    Liu CS; Lii CK; Ou CC; Tsai CH; Wei YH; Chen HW
    Chem Biol Interact; 2000 Jul; 127(2):125-37. PubMed ID: 10936228
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Autoantibodies against malondialdehyde-modified LDL are elevated in subjects with an LDL subclass pattern B.
    Jansen H; Ghanem H; Kuypers JH; Birkenhäger JC
    Atherosclerosis; 1995 Jun; 115(2):255-62. PubMed ID: 7661884
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Relationship of Autoantibodies to MDA-LDL and ApoB-Immune Complexes to Sex, Ethnicity, Subclinical Atherosclerosis, and Cardiovascular Events.
    Prasad A; Clopton P; Ayers C; Khera A; de Lemos JA; Witztum JL; Tsimikas S
    Arterioscler Thromb Vasc Biol; 2017 Jun; 37(6):1213-1221. PubMed ID: 28473443
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Autoantibodies against oxidatively-modified LDL in uremic patients undergoing dialysis.
    Maggi E; Bellazzi R; Gazo A; Seccia M; Bellomo G
    Kidney Int; 1994 Sep; 46(3):869-76. PubMed ID: 7996809
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antibodies to oxidized LDL and LDL-containing immune complexes as risk factors for coronary artery disease in diabetes mellitus.
    Lopes-Virella MF; Virella G; Orchard TJ; Koskinen S; Evans RW; Becker DJ; Forrest KY
    Clin Immunol; 1999 Feb; 90(2):165-72. PubMed ID: 10080827
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Autoantibody titers to oxidized low-density lipoprotein in patients with coronary atherosclerosis.
    Bui MN; Sack MN; Moutsatsos G; Lu DY; Katz P; McCown R; Breall JA; Rackley CE
    Am Heart J; 1996 Apr; 131(4):663-7. PubMed ID: 8721636
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Relationship of IgG and IgM autoantibodies to oxidized low density lipoprotein with coronary artery disease and cardiovascular events.
    Tsimikas S; Brilakis ES; Lennon RJ; Miller ER; Witztum JL; McConnell JP; Kornman KS; Berger PB
    J Lipid Res; 2007 Feb; 48(2):425-33. PubMed ID: 17093289
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.